Key facts
- This page summarizes Matthew Pauls's Form 4 filing for PALVELLA THERAPEUTICS, INC. (PVLA).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 01 Jul 2026, 16:06.
Matthew Pauls - 29 Jun 2026 Form 4 Insider Report for PALVELLA THERAPEUTICS, INC. (PVLA)
- Reporting relationship
- Director
- Issuer ticker
- PVLA
- Reported as of
- 29 Jun 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Jul 2026, 16:06:02 UTC
- Prior SEC filing
- 18 May 2026
- Next SEC filing
- 07 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kathleen A. McGowan, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Matthew Pauls filed Form 4 for PALVELLA THERAPEUTICS, INC. (PVLA) on 01 Jul 2026.
Change
- Previous filing in this sequence was filed on 18 May 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001573429
Primary reporting owner
Pauls Matthew
- Relationship
- Director
- Address
- C/O PALVELLA THERAPEUTICS, INC., 353 W. LANCASTER AVENUE, SUITE 200, WAYNE
- Signature
- /s/ Kathleen A. McGowan, Attorney-in-Fact
- Signature date
- 01 Jul 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PVLA
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- Shares
- +6,000
- Change %
- Price
- $0.000000*
- Shares after
- 6,000
- Date
- 29 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,000
- Exercise price
- $154.84
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The options vest in 36 equal monthly installments, subject to the Reporting Person's continued service as of each such vesting date.